Table 1 Inclusion/Exclusion Criteria Applied [25]

Population

Humans

Animals only

All ages

Plants only

All sexes

Infection with antimicrobial resistant organism (or similar such as Extended Spectrum Beta-lactamase producing organisms). This includes future predictions of related infected populations, such as in the case of a “post-antibiotic” era

Outcomes

Associated health burden, including mortality and morbidity

Health-Related Quality of Life only

Associated healthcare cost burden, including resource use and opportunity cost

Molecular biology only

Economic burden, including loss of productivity

Epidemiology only

Burden from not being able to use antibiotics in ways previously or currently used in healthcare, including reduced surgery or chemotherapy

Outcomes associated with the evaluation of an intervention only

Study design

Case–control studies

Editorials

Cohort studies

Letters

Cross–sectional studies

Case series reports

Longitudinal studies

Conference reports

Randomised controlled trials

Evaluations of interventions

Modelling studies

Reviews

Economic Evaluations